Africa Eastern and Southern vs Sweden: Antiretroviral therapy coverage
Africa Eastern and Southern
83.9%
in 2024
Sweden
95.0%
in 2022
Africa Eastern and Southern rank
4th
Sweden rank
3rd
Antiretroviral therapy coverage over time
- Africa Eastern and Southern
- Sweden
How they compare
Sweden currently reports 95.0% against 83.9% in Africa Eastern and Southern, a difference of 11.1%.
That makes Sweden's figure about 1.1 times Africa Eastern and Southern's.
Across all 23 years both countries report, Sweden has been ahead every year.
Africa Eastern and Southern ranks 4th and Sweden ranks 3rd of 23 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Africa Eastern and Southern | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.0% | 49.0% | 43.0% | Sweden |
| 2010s | 49.5% | 91.5% | 42.0% | Sweden |
| 2020s | 76.6% | 95.3% | 18.7% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Africa Eastern and Southern or Sweden?
- Sweden, at 95.0% against 83.9% in Africa Eastern and Southern as of 2022.
- What is the difference in antiretroviral therapy coverage between Africa Eastern and Southern and Sweden?
- 11.1%, with Sweden ahead.
- How many years of comparable data are there for Africa Eastern and Southern and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do Africa Eastern and Southern and Sweden rank globally for antiretroviral therapy coverage?
- Africa Eastern and Southern ranks 4th and Sweden ranks 3rd of 23 groups.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.